Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,435,118 papers from all fields of science
Search
Sign In
Create Free Account
Bisoprolol / Hydrochlorothiazide
Known as:
BISOPROLOL/HYDROCHLOROTHIAZIDE
, bisoprolol - hydrochlorothiazide
, bisoprolol, hydrochlorothiazide drug combination
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (3)
Antihypertensive Agents
Drug Combinations
Hydrochlorothiazide
Bisoprolol
Bisoprolol Fumarate 5 MG / Hydrochlorothiazide 6.25 MG Oral Tablet
Bisoprolol Fumarate/Hydrochlorothiazide
Maxsoten
Narrower (1)
Ziac
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND…
O. Ostroumova
,
A. Kochetkov
,
M. Lopukhina
2017
Corpus ID: 80240607
Aim . To study the characteristics of the daily profile of blood pressure (BP) and heart damage in patients with essential…
Expand
Review
2014
Review
2014
Cochrane in context: pharmacological interventions for hypertension in children.
S. Chaturvedi
,
Deborah H Lipszyc
,
C. Licht
,
J. Craig
,
R. Parekh
Evidence-Based Child Health A Cochrane Review…
2014
Corpus ID: 20269721
BACKGROUND Hypertension is a major risk factor for stroke, coronary artery disease and kidney damage in adults. There is a…
Expand
2013
2013
Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa
C. E. Osakwe
,
L. Jacobs
,
+17 authors
J. Staessen
Blood Pressure
2013
Corpus ID: 4681753
Abstract Background. Compared with Caucasians, African Americans have lower heart rate variability (HRV) in the high-frequency…
Expand
Review
2009
Review
2009
Low-dose Fixed Combination of Bisoprolol/Hydrochlorothiazide as First Line for Hypertension: A Review of the Rationale and Clinical Evidence
D. Papadopoulos
,
V. Papademetriou
Angiology
2009
Corpus ID: 46427060
Essential hypertension is a heterogeneous multifactorial disease. Data from the National Health and Nutritional Examination…
Expand
2007
2007
An Erythrodermic Variant of Pemphigus Foliaceus with Puzzling Histologic and Immunopathologic Features
J. Peterson
,
S. Worobec
,
L. Chan
Journal of Cutaneous Medicine and Surgery
2007
Corpus ID: 10817420
Background: Pemphigus foliaceus is an autoimmune blistering disorder that affects the skin owing to autoantibodies against…
Expand
2000
2000
Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
A. Bénétos
,
Silla Consoli
,
A. Safavian
,
Arnaud Dubanchet
,
M. Safar
American Heart Journal
2000
Corpus ID: 8539715
BACKGROUND Several studies have shown the benefits of antihypertensive treatment in elderly patients in terms of cardiovascular…
Expand
1998
1998
Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.
V. Papademetriou
,
L. Prisant
,
J. Neutel
,
M. Weir
American Journal of Cardiology
1998
Corpus ID: 1723443
1998
1998
E087 Assessment of sexual dysfunction with bisoprolol/hydrochlorothiazide, bisoprolol, hydrochlorothiazide, enalapril and amlodipine
L. Prisant
,
M. Weir
1998
Corpus ID: 71212634
1993
1993
Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
P. Zachariah
,
F. Messerli
,
W. Mroczek
Clinical Therapeutics
1993
Corpus ID: 20880130
Two recent, multicenter, double-blind, placebo-controlled studies established the efficacy and safety of low-dose bisoprolol…
Expand
1993
1993
A clinical trial evaluating the 24‐hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension
A. Lewin
,
M. Lueg
,
Shari Targum
,
Pamela Cardenas
Clinical Cardiology
1993
Corpus ID: 22059676
This study used 24‐h ambulatory blood pressure (BP) monitoring to investigate the effectiveness of a novel low‐dose combination…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE